A new trading day began On Friday, with Clearside Biomedical Inc (NASDAQ: CLSD) stock price down -7.80% from the previous day of trading, before settling in for the closing price of $0.42. CLSD’s price has ranged from $0.29 to $1.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.40%. Meanwhile, its annual earnings per share averaged 32.52%. With a float of $61.36 million, this company’s outstanding shares have now reached $77.27 million.
Let’s determine the extent of company efficiency that accounts for 32 employees. In terms of profitability, gross margin is 89.61%, operating margin of -1804.6%, and the pretax margin is -2098.74%.
Clearside Biomedical Inc (CLSD) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Clearside Biomedical Inc is 21.04%, while institutional ownership is 13.71%. The most recent insider transaction that took place on Feb 24 ’25, was worth 13,800. In this transaction Director of this company bought 15,000 shares at a rate of $0.92, taking the stock ownership to the 176,141 shares. Before that another transaction happened on Nov 01 ’24, when Company’s Chief Medical Officer bought 36,500 for $1.00, making the entire transaction worth $36,500. This insider now owns 100,000 shares in total.
Clearside Biomedical Inc (CLSD) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 32.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.71% during the next five years compared to 10.40% growth over the previous five years of trading.
Clearside Biomedical Inc (NASDAQ: CLSD) Trading Performance Indicators
Here are Clearside Biomedical Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.41, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.30 in one year’s time.
Technical Analysis of Clearside Biomedical Inc (CLSD)
Looking closely at Clearside Biomedical Inc (NASDAQ: CLSD), its last 5-days average volume was 1.67 million, which is a drop from its year-to-date volume of 1.99 million. As of the previous 9 days, the stock’s Stochastic %D was 34.91%.
During the past 100 days, Clearside Biomedical Inc’s (CLSD) raw stochastic average was set at 12.07%, which indicates a significant decrease from 15.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1209 in the past 14 days, which was higher than the 0.0646 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7256, while its 200-day Moving Average is $0.9058. However, in the short run, Clearside Biomedical Inc’s stock first resistance to watch stands at $0.4094. Second resistance stands at $0.4347. The third major resistance level sits at $0.4494. If the price goes on to break the first support level at $0.3694, it is likely to go to the next support level at $0.3547. Should the price break the second support level, the third support level stands at $0.3294.
Clearside Biomedical Inc (NASDAQ: CLSD) Key Stats
With a market capitalization of 29.85 million, the company has a total of 77,709K Shares Outstanding. Currently, annual sales are 1,660 K while annual income is -34,350 K. The company’s previous quarter sales were 2,330 K while its latest quarter income was -8,220 K.
